Page 1 Nyrada Inc. Level 3, 828 Pacific Highway, Gordon NSW 2072 ARBN 625 401 818 28 August 2026 Sydney, Australia Notice of Change of Interests of Substantial Securityholder (“Notice”) Nyrada Inc (ASX: NYR), a clinical-stage biotechnology company focused on ...
Change in substantial holding - M Azzi
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nyrada
- Cleansing Statement
- Application for quotation of securities - NYR
- Xolatryp Demonstrates Cardioprotection in Preclinical Study
- Nyrada Full Year Results FY2026
- Annual Report for year ended 30 June 2026
Later from Nyrada
- Investor Presentation- Evans&Partners Small Cap Healthcare
- Trading Halt
- Nyrada Successfully Raises AU$12.0 Million Via Placement
- Cap Raise Deck-Building the Future of TRPC-based Therapies
- Proposed issue of securities - NYR
Follow Nyrada into a list and get an email when it puts out news.
Follow Nyrada